ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,940Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 783

$978K Total Retail Price of All Prescriptions

Rank: 51 out of 783

501 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

27% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 651 409 S3 1 2
AMLODIPINE BESYLATE 575 466 2 5
SIMVASTATIN 367 310 3 3
FUROSEMIDE 357 304 4 7
OMEPRAZOLE 350 271 5 6
LISINOPRIL 335 256 6 4
LEVOTHYROXINE SODIUM 308 234 7 1
GABAPENTIN 293 219 8 15
WARFARIN SODIUM 255 234 9 10
METOPROLOL TARTRATE 252 229 10 9
HYDROCHLOROTHIAZIDE 225 170 11 12
METOPROLOL SUCCINATE 212 189 12 13
POTASSIUM CHLORIDE 204 172 13 16
METFORMIN HCL 194 136 14 8
ATORVASTATIN CALCIUM 190 141 15 11
MIRTAZAPINE 175 156 16 52
CITALOPRAM HBR 174 151 17 19
CRESTOR 172 137 18 27
TRAZODONE HCL 171 126 19 39
PRAVASTATIN SODIUM 165 136 20 14
LOSARTAN POTASSIUM 163 144 21 18
GLIMEPIRIDE 162 111 22 34
DONEPEZIL HCL 146 146 23 24
ZOLPIDEM TARTRATE 146 114 23 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 115 25 33
TAMSULOSIN HCL 126 100 26 26
CARVEDILOL 123 103 27 21
MELOXICAM 122 92 28 37
CYMBALTA 121 49 29 35
ALLOPURINOL 117 101 30 31
LANTUS 109 103 31 38
TRAMADOL HCL 108 81 32 20
HUMALOG 107 102 33 101
FAMOTIDINE 104 65 34 55
PANTOPRAZOLE SODIUM 101 88 35 30
OXYCODONE HCL-ACETAMINOPHEN 98 47 S2 36 86
POLYETHYLENE GLYCOL 3350 94 70 37 43
CLOPIDOGREL 94 73 37 29
FLUTICASONE PROPIONATE 92 49 39 46
ISOSORBIDE MONONITRATE ER 89 88 40 40
OXYCODONE-ACETAMINOPHEN 87 44 S2 41 76
CYCLOBENZAPRINE HCL 86 37 R 42 63
NAMENDA 85 73 43 32
CLONIDINE HCL 81 45 44 60
NEXIUM 79 60 45 28
LOSARTAN-HYDROCHLOROTHIAZIDE 76 62 46 53
CEPHALEXIN 75 70 47 70
SERTRALINE HCL 74 59 48 22
PROAIR HFA 73 49 49 56
PEN NEEDLE 73 48 49 103
IBUPROFEN 72 44 51 115
CARBIDOPA-LEVODOPA 72 69 51 88
BENAZEPRIL HCL 72 59 51 85
NOVOLOG 71 65 54 81
OXYCONTIN 71 22 S2 54 171
FENTANYL 71 63 S2 54 65
NAPROXEN 70 19 57 104
LEVOFLOXACIN 70 48 57 75
RISPERIDONE 70 61 57 67
SPIRIVA 69 64 60 59
ALENDRONATE SODIUM 68 68 61 25
ADVAIR DISKUS 66 45 62 50
FLUOXETINE HCL 65 46 63 45
ROPINIROLE HCL 65 51 63 74
DILTIAZEM 24HR CD 62 61 65 118
DIVALPROEX SODIUM 62 51 65 72
ATENOLOL 59 55 67 17
CLOTRIMAZOLE-BETAMETHASONE 58 39 68 189
DIOVAN HCT 57 33 69 94
OXYBUTYNIN CHLORIDE 56 51 70 96
KLOR-CON M20 56 46 70 48
DOXAZOSIN MESYLATE 55 52 72 87
NYSTATIN 54 48 73 106
PLAVIX 53 41 74 51
METOCLOPRAMIDE HCL 52 27 75 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.